Late effects and survival of children with malignant solid tumours in northern Finland: a single-centre cohort study

The global survival rates for childhood cancers are high: approximately 80% of affected children will survive. Nevertheless, the burden of treatment for survivors is also high as three-quarters experience late effects of varying severity following cancer treatment. The aims of this study were to eva...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 2022-06, Vol.181 (6), p.2263-2272
Main Authors: Kortelainen, Sanni, Harju, Tekla, Juntti, Hanna, Pokka, Tytti, Niinimäki, Riitta
Format: Article
Language:English
Subjects:
Cancer
Cancer Survivors
Central nervous system
Child
Children
Cohort analysis
Cohort Studies
Disease Progression
Finland - epidemiology
Hearing loss
Humans
Lymphoma
Medical records
Medicine
Medicine & Public Health
Neoplasms - epidemiology
Neoplasms - therapy
Original
Original Article
Patients
Pediatrics
Solid tumors
Survival
Survivors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The global survival rates for childhood cancers are high: approximately 80% of affected children will survive. Nevertheless, the burden of treatment for survivors is also high as three-quarters experience late effects of varying severity following cancer treatment. The aims of this study were to evaluate the treatment-related late effects of patients with childhood solid tumour in northern Finland and to report their survival rates. Our study included 104 patients treated for malignant solid tumours, excluding central nervous system tumours and lymphomas, between 1990 and 2015. Information regarding the type of late effects as well as other clinical data were obtained from the patients’ medical records. Late effects were observed in 65 (63%) patients, and almost half (40%) of the patients displayed more than one late effect. The most common late effect was hearing loss ( n  = 20). The 5-year survival rate in our study was 75%.    Conclusion : Our results highlight the importance of long-term follow-up for childhood cancer survivors. As survivors age and survival rates improve, late effects and their impact on patient health as well as the value of surveillance must be considered. What is Known: • Up to three-quarters of childhood cancer survivors experience treatment-related late effects. What is New: • The 5-year survival rate and the prevalence of late effects amongst childhood solid tumour patients treated in northern Finland are in line with findings from previous studies.
ISSN:1432-1076
0340-6199
1432-1076
DOI:10.1007/s00431-022-04399-7